EFFECTOR THERAPEUTICS INC (EFTR)

US28202V2079 - Common Stock

0.18  -0.09 (-32.56%)

After market: 0.155 -0.02 (-13.89%)

Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to EFTR. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 11.22. This target is 6133.33% above the current price.
EFTR was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about EFTR.
In the previous month the buy percentage consensus was at a similar level.
EFTR was analyzed by 8 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 0.1810.1011.2211.2212.60 - 5,511.11% 6,133.33% 6,133.33% 6,900.00%
Up and Down Grades
Date Firm Action Rating
2024-03-28 HC Wainwright & Co. Reiterate Buy -> Buy
2024-02-06 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-14 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-24 HC Wainwright & Co. Initiate Buy
2023-05-26 Stifel Upgrade Hold -> Buy
2023-05-10 Credit Suisse Maintains Outperform
2023-03-09 Credit Suisse Maintains Outperform
2023-01-09 JMP Securities Maintains Market Outperform
2023-01-06 Credit Suisse Maintains Outperform
2022-11-17 JMP Securities Maintains Market Outperform
2022-08-11 JMP Securities Maintains Market Outperform
2022-01-25 JMP Securities Maintains Market Outperform
2022-01-25 Stifel Downgrade Buy -> Hold
2022-01-25 Credit Suisse Maintains Outperform
2021-11-09 Stifel Upgrade Hold -> Buy
2021-10-12 Credit Suisse Initiate Outperform
2021-10-04 Mizuho Initiate Buy
2021-09-21 JMP Securities Initiate Market Outperform
2021-09-20 Stifel Initiate Hold
2021-09-13 Cantor Fitzgerald Initiate Overweight